DIVISLAB.NS

Divi's Laboratories Limited DIVISLAB.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode DIVISLAB.NS TORNTPHARM.BO TORNTPHARM.NS MANKIND.NS MANKIND.BO DRREDDY.BO DRREDDY.NS ZYDUSLIFE.NS ZYDUSLIFE.BO LUPIN.NS
6M 11.43 % 10.63 % 10.61 % -5.19 % -5.00 % 9.76 % 9.68 % 17.22 % 17.29 % -5.10 %
YTD 8.46 % 5.10 % 5.04 % -15.11 % -15.26 % -5.84 % -5.87 % 2.64 % 2.70 % -17.87 %
1Y 13.22 % 7.59 % 7.52 % -4.69 % -4.70 % -3.19 % -3.29 % 1.14 % 1.18 % -8.90 %
3Y 82.34 % 128.88 % 129.11 % 71.95 % 71.82 % 47.31 % 47.20 % 141.95 % 142.02 % 185.32 %
5Y 112.93 % 164.57 % 164.51 % 71.95 % 71.82 % 28.35 % 28.31 % 134.82 % 134.64 % 95.53 %
10Y 504.31 % 353.97 % 354.14 % 71.95 % 71.82 % 54.08 % 53.84 % 125.57 % 125.79 % -6.59 %
From the beginning 74 667.31 % 69 476.55 % 17 306.20 % 71.95 % 71.82 % 3 152.33 % 6 505.33 % -51.44 % 15 450.54 % 23 998.01 %

Dividend

Divi's Laboratories Limited

Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited

Mankind Pharma Limited

Mankind Pharma Limited

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited

Zydus Lifesciences Limited

Zydus Lifesciences Limited

Lupin Limited